Oncotarget

ISSNs: 1949-2553

Additional searchable ISSN (Electronic): 1949-2553

Impact Journals

Scopus rating (2018): CiteScore 3.86 SJR 1.575 SNIP 0.904

Journal

Publications

  1. 2018
  2. S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

    Casara, P., Davidson, J., Claperon, A., Toumelin-Braizat, G. L., Vogler, M., Bruno, A., Chanrion, M., Lysiak-Auvity, G., Diguarher, T. L., Starck, J-B., Chen, I., Whitehead, N., Graham, C., Matassova, N., Dokurno, P., Pedder, C., Wang, Y., Qiu, S., Girard, A-M., Schneider, E. & 18 othersGravé, F., Studeny, A., Guasconi, G., Rocchetti, F., Maïga, S., Henlin, J-M., Colland, F., Kraus-Berthier, L., Gouill, S. L., Dyer, M. JS., Hubbard, R., Wood, M., Amiot, M., Cohen, G. M., Hickman, J. A., Morris, E., Murray, J. & Geneste, O., 13 Apr 2018

    Article in Oncotarget

  3. 2017
  4. 2016
  5. Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia

    Laidlaw, K. M. E., Berhan, S., Liu, S., Silvestri, G., Holyoake, T. L., Frank, D. A., Aggarwal, B., Bonner, M. Y., Perrotti, D., Jørgensen, H. G. & Arbiser, J. L., 9 Aug 2016

    Article in Oncotarget

  6. 2015
  7. CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations

    Khanna, A., Rane, J. K., Kivinummi, K. K., Urbanucci, A., Helenius, M. A., Tolonen, T. T., Saramäki, O. R., Latonen, L., Manni, V., Pimanda, J. E., Maitland, N. J., Westermarck, J. & Visakorpi, T., 19 Apr 2015

    Article in Oncotarget

  8. Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

    Santer, F. R., Erb, H. H. H., Oh, S. J., Handle, F., Feiersinger, G. E., Luef, B., Bu, H., Schäfer, G., Ploner, C., Egger, M., Rane, J. K., Maitland, N. J., Klocker, H., Eder, I. E. & Culig, Z., 20 Mar 2015

    Article in Oncotarget

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations